Related by context. All words. (Click for frequent words.) 79 Meets Primary Endpoint 78 Investigational Treatment 77 Advanced Melanoma 77 Overactive Bladder 76 Patients Treated With 76 Improves Outcomes 76 Renal Cell Carcinoma 76 Phase 2b Clinical Trial 76 Prolongs Survival 76 Myelodysplastic Syndromes 76 Slow Progression 75 Oral Fingolimod 75 Treated Patients 75 Patients Receiving 75 Rheumatoid Arthritis Patients 75 Benign Prostatic Hyperplasia 75 Complicated Skin 75 Clinical Trial Results 75 IND Application 75 Long Term Efficacy 75 Chronic Sinusitis 74 Antitumor Activity 74 Relapsed Refractory 74 Previously Treated 74 Drug Prevents 74 Cutaneous T 74 Phase III Trial 74 Improved Survival 74 Phase IIb Trial 74 Malignant Melanoma 74 HER2 Positive Breast Cancer 74 Pivotal Phase III 74 Phase IIb Clinical Trial 74 Initiates Clinical Trial 74 Chronic Myeloid Leukemia 74 Disease Modifying 74 Adjunctive Therapy 74 Metastatic Prostate Cancer 74 Pooled Analysis 73 Investigational Compound 73 Demonstrates Efficacy 73 Demonstrates Positive 73 Inflammatory Diseases 73 Completes Patient Enrollment 73 Adjuvant Treatment 73 Novel Oral 73 Severe Sepsis 73 Improves Survival 73 Treatment Shows Promise 73 Hormone Refractory Prostate Cancer 73 Tyrosine Kinase Inhibitor 73 Heart Failure Patients 73 Patient Enrollment 73 Phase 2a Clinical Trial 73 Mouse Model 73 Novel Treatments 73 Drug Shows Promise 73 Elderly Patients 73 Improve Survival 73 FDA Approvals 73 Allergic Rhinitis 73 Shows Promising 73 Shows Efficacy 73 Successfully Treated 73 Slows Progression 73 Breast Cancer Recurrence 73 Granted Orphan Drug 73 Secondary Hyperparathyroidism 73 Pivotal Phase 73 Prophylactic Treatment 73 Chronic Hepatitis B 73 Lung Cancer Drug 73 Drug Candidate 72 Newly Diagnosed Multiple Myeloma 72 Study Evaluating 72 Treating Chronic 72 Phase 2b Trial 72 Inflammatory Markers 72 Pivotal Study 72 Phase III Clinical Trial 72 Knee Osteoarthritis 72 Shows Promise Against 72 Combination REOLYSIN R 72 Dupuytren Contracture 72 Receives Orphan Drug Designation 72 Decitabine 72 Diabetic Neuropathy 72 Bronchiectasis 72 Gastrointestinal Stromal Tumors 72 Fungal Infections 72 Acute Exacerbations 72 Myeloma Patients 72 Relapsing Remitting Multiple Sclerosis 72 Combination Treatment 72 Trial Evaluating 72 Hyperlipidemia 72 Golimumab 72 Chronic Bronchitis 72 Gene Linked 72 Investigational Agent 72 Atypical Hemolytic Uremic Syndrome 72 Metastatic Colorectal Cancer 72 Naive Patients 72 Relapsed Multiple Myeloma 72 Endometrial Cancer 72 Pivotal Clinical Trial 72 Subgroup Analysis 72 Metastatic Melanoma 72 Pulmonary Arterial Hypertension 72 Presents Positive 72 atypical Hemolytic Uremic Syndrome 72 myelodysplastic myeloproliferative diseases 72 Treatment Reduces 72 Severe Asthma 72 Interferon Beta 72 Limb Ischemia 72 Initiate Phase 72 Follicular Lymphoma 72 SPRYCEL ® 72 Genes Predict 72 Systemic Sclerosis 71 Chronic Heart Failure 71 Leukemias 71 Myelodysplastic Syndrome MDS 71 Soft Tissue Sarcoma 71 Phase IIa Clinical Trial 71 Oral Calcitonin 71 Enlarged Prostate 71 Pivotal Trial 71 Eculizumab 71 Phase 2a Trial 71 Anti Tumor 71 Treatment Naive Patients 71 chronic eosinophilic leukemia 71 Hormone Receptor Positive 71 R lenalidomide 71 Advanced Colorectal Cancer 71 Prospective Randomized 71 Disease Progression 71 Transdermal Patch 71 Emerging Therapies 71 Patients Suffering 71 Initiates Enrollment 71 Hepatocellular Carcinoma 71 Refractory Hodgkin Lymphoma 71 Psoriasis Drug 71 Monotherapy 71 Prostate Cancer Patients 71 Syncria R 71 NASH Huntington 71 Atopic Dermatitis 71 Achieves Primary Endpoint 71 Inhaled Corticosteroids 71 Patients Treated 71 FDA Okays 71 Plaque Psoriasis 71 Proves Effective 71 Survival Benefit 71 Myelofibrosis 71 Phase 2b Study 71 Osteoporosis Drug 71 Autoimmune Disease 71 Demonstrates Significant 71 Rheumatoid Arthritis Drug 71 Initiate Clinical Trial 71 Brentuximab Vedotin SGN 71 Treatment Resistant 71 Adjuvant Chemotherapy 71 Bosutinib 71 Aflibercept 71 Lowers Risk 71 Pediatric Patients 71 Osteoporosis Drugs 71 Cholesterol Lowering Drug 71 Systemic lupus erythematosus SLE 71 Non Invasive Treatment 71 metastatic malignant 71 complement inhibitor eculizumab 71 Showed Significant 71 Blood Pressure Drug 71 Antiplatelet 71 Kinase Inhibitors 71 FOLOTYN ® 71 TNF Blockers 71 Preclinical Models 71 First Patient Enrolled 70 Demonstrates Potent 70 TNF Tumor Necrosis Factor 70 Hepatic Encephalopathy 70 HCV Protease Inhibitor 70 Anthracycline 70 Advanced Pancreatic Cancer 70 ACE Inhibitors 70 Safinamide 70 Shows Statistically Significant 70 Oral Formulation 70 Dose Escalation 70 Nilotinib 70 Dose Ranging Study 70 Alemtuzumab 70 Peginterferon 70 Submits NDA 70 See CLINICAL PHARMACOLOGY 70 Prostate Cancer Vaccine 70 Phase III Trials 70 Gastric Cancer 70 Juvenile Idiopathic Arthritis 70 Previously Untreated 70 Diabetic Nephropathy 70 Fabry Disease 70 Renal Cancer 70 Clinical Trial Evaluating 70 Sleep Disturbances 70 Effectively Treats 70 Serious Infections 70 Preclinical Data 70 II Clinical Trial 70 Neovascular Age Related Macular 70 JAK Inhibitor 70 Initiates Clinical 70 NICE Recommends 70 Expanded Indication 70 Shown Effective 70 Kidney Transplant Patients 70 Angioedema 70 Tyrosine Kinase Inhibitors 70 PEGylated Fab fragment 70 Pulmonary Arterial Hypertension PAH 70 Tezampanel 70 erythematosus 70 Cell Lymphoma 70 Completes Enrollment 70 Initiates Phase II 70 Immunotherapeutic 70 Treatable 70 Renal Impairment 70 Partial Onset Seizures 70 arthritis PsA 70 Newly Diagnosed Patients 70 Beta Blocker 70 Non Alcoholic Fatty 70 Patients Undergoing 70 Breast Cancer Treatment 70 Predict Risk 70 Stomach Cancer 70 Proven Effective 70 Adjuvant Therapy 70 Growth Hormone Deficiency 70 Adjunctive 70 Diabetic Foot Ulcer 70 Kidney Transplant Recipients 70 Clostridium difficile Infection 70 Single Dose 70 Begins Dosing 70 Bevacizumab 70 Advanced Prostate Cancer 70 Combo Therapy 70 Lung Cancer Survival 70 Fondaparinux 70 Drug Resistant 70 Chronic HCV 70 Anti Tumor Activity 70 NAVISTAR R 70 Acute Heart Failure 70 Hypercholesterolemia 70 Vaccine Candidate 70 Significantly Improved 70 FDA Clears 70 Relapsing Multiple Sclerosis 70 Gout Drug 70 Cypher Sirolimus 70 Files IND 70 Unresectable 70 Asthma COPD 70 Mylan Receives Approval 70 Advanced Renal Cell 70 Acute Ischemic Stroke 70 Drug Fails 70 Receives Orphan Drug 70 Acute Attacks 70 Reduces Mortality 70 Progenitor Cells 70 Is Well Tolerated 70 Investigational Drug 70 Placebo Controlled Study 69 Schizophrenia Treatment 69 Rheumatoid Arthritis RA 69 Sevelamer 69 Unfractionated Heparin 69 Vaccine Adjuvant 69 Inflammatory Disease 69 Malignant Glioma 69 Stem Cell Treatment 69 Pegylated Interferon 69 ORLive Presents 69 Bone Fracture 69 induced macular edema 69 Obesity Linked 69 ST Elevation Myocardial 69 Enzyme Replacement Therapy 69 Vicriviroc 69 Skeletal Muscle 69 Chronic Constipation 69 Lung Cancer Trial 69 CYT# potent vascular disrupting 69 Tiotropium 69 Carotid Stenting 69 Novel Antibiotic 69 Antiangiogenic 69 Migraine Drug 69 Gene Variant 69 Lung Cancer Patients 69 Lupus Drug 69 Tumor Growth 69 Etanercept 69 Fracture Risk 69 Muscle Wasting 69 Glatiramer Acetate 69 Renal Function 69 Demonstrates Potential 69 Generalized Anxiety Disorder 69 Significantly Reduced 69 HER2 Positive 69 Chronic Myelogenous Leukemia 69 Node Positive 69 SNT-MC#/idebenone 69 Uterine Fibroids 69 Microalbuminuria 69 Chronic Hepatitis C 69 Hypertensive Patients 69 Hepatocellular Carcinoma HCC 69 Therapeutic Potential 69 PRN FDA Approves 69 Sustained Reduction 69 Pemphigus 69 Randomized Study 69 Drug Combo 69 hyperphenylalaninemia HPA due 69 Study Shows Promise 69 Premenopausal Women 69 bone marrow reticulin deposition 69 Minimally Invasive Treatment 69 Intravitreal 69 Vitrasert R 69 pan HDAC inhibitor 69 Brain Metastases 69 Septic Shock 69 Colorectal Cancer Patients 69 Chronic Lymphocytic Leukemia 69 Synthetic Peptide 69 Daclizumab 69 Artery Disease 69 Successfully Completes Phase 69 Novel Compound 69 Recombinant Human 69 IL# PE#QQR 69 Phase 1b Clinical Trial 69 NDA Submission 69 Initiate Phase III 69 Benign prostatic hyperplasia BPH 69 Bone Metastases 69 Kidney Function 69 Postmenopausal Osteoporosis 69 FDA Approves Drug 69 Initiates Phase III 69 ® lenalidomide 69 Epilepsy Drug 69 Bipolar Depression 69 Stakeholder Opinions 69 FDA Accepts 69 hypereosinophilic syndrome 69 Aryplase 69 Intracranial Aneurysms 69 Well Tolerated 69 Study Demonstrates 69 Liver Failure 69 Androgen Deprivation Therapy 69 Epidermal Growth Factor Receptor 69 Randomized Phase 69 Sipuleucel T 69 Ovarian Cancer Patients 69 Romidepsin 69 Nebulized 69 dasatinib Sprycel ® 69 INSPIRE Trial Phase III 69 Phase III Pivotal 69 Randomized Trials 69 Nicotine Vaccine 69 Pegylated 69 Irritable Bowel 69 Epratuzumab 69 biliary tract cancer 69 Study Showed 69 Cell Transplants 69 Personalized Immunotherapy 69 Recurrent Breast Cancer 69 Teva Provides Update 69 Data Suggest 69 Mayo Clinic Study Finds 69 Sapacitabine 68 Levels Linked 68 Adenoma 68 Paraplatin ® 68 Subtypes 68 Effective Treatments 68 Diagnostic Criteria 68 Rheumatoid 68 Lenalidomide 68 Rotavirus Vaccine 68 Basal Cell 68 Invasive Breast Cancer 68 Monoclonal Antibody 68 treat benign prostatic 68 Diabetic Neuropathic Pain 68 metastatic neuroendocrine tumors 68 Thromboembolic 68 Mg Usa 68 Transplant Rejection 68 Peripheral Arterial 68 Genes Linked 68 hyperplasia BPH 68 R Saizen R 68 Vertebral Compression Fractures 68 Degarelix 68 Chronic Lymphocytic Leukemia CLL 68 IMiDs ® 68 toenail onychomycosis 68 Castration Resistant Prostate Cancer 68 Invasive Fungal Infections 68 Cognitive Impairment 68 Relapsed Refractory Multiple Myeloma 68 Hyperuricemia 68 Often Misdiagnosed 68 Bone Marrow Transplants 68 Antigen Specific 68 Gene Mutation 68 Preclinical Study 68 FDA APPROVES 68 Corneal Transplant 68 Desvenlafaxine Succinate 68 Muscle Function 68 Genetic Variant 68 Acute Bacterial Sinusitis ABS 68 Chronic Renal Failure 68 Diabetic Patients 68 Chemotherapy induced 68 Kinase Inhibitor 68 Hemodialysis Patients 68 Metastatic Renal Cell Carcinoma 68 Lubiprostone 68 Postmenopausal Women 68 Statistically Significant 68 Appears Safe 68 Aggressive Prostate Cancer 68 Virus Linked 68 IN PATIENTS WITH 68 Protein Linked 68 Lymphoid 68 metastatic GIST 68 Novel Mechanism 68 ALN HPN 68 Sustained Efficacy 68 Hepatitis B Vaccine 68 Metabolic Disorder 68 pralatrexate injection folate analogue 68 Clinical Trial Data 68 PEGINTRON TM 68 Demonstrate Significant 68 Combination Therapy 68 Protease Inhibitor 68 Demonstrated Significant 68 Surgical Treatment 68 Multiple Myeloma Patients 68 Antipsychotic 68 Romiplostim 68 Coronary Artery Bypass Graft 68 essential thrombocythemia ET 68 Phase Ib Clinical Trial 68 Bazedoxifene 68 adalimumab Humira 68 Squamous Cell Carcinoma 68 Minimally Invasive Procedure 68 Stent Restenosis 68 Left Ventricular Hypertrophy 68 LHON 68 Hsp# Inhibitor 68 Papillary 68 Chronic Inflammatory 68 Amgen Neulasta R 68 Anticancer Agent 68 psoriasis rheumatoid arthritis 68 Pegloticase 68 Contrast Agent 68 Systemic Delivery 68 Sinus Infections 68 #-# Full Text 68 Autoimmune Diseases 68 Therapeutic Targets 68 Controlled Study 68 Resistant Hypertension 68 Squamous 68 Arthritis Drug 68 Clinically Tested 68 Systemic Lupus Erythematosus SLE 68 Immunologic 68 Presents Preclinical 68 Breast Cancers 68 Demonstrates Sustained 68 HDAC Inhibitor 68 Autoimmune Disorders 68 Therapeutic Efficacy 68 Microplasmin 68 Guidelines Issued 68 Premature Infants 68 Polymerase Inhibitor 68 Lung Tumors 68 Efficacy Trial 68 Ulcerative Colitis 68 Platinol ® 68 Immunomedics Announces 68 Successfully Treats 68 Efficacious 68 HeFH 68 Bone Marrow Cells 68 Non Alcoholic Steatohepatitis 68 Genetic Mutation 68 Clinical Outcome 68 Idiopathic Pulmonary Fibrosis 68 Anemia Drug 68 Temodar ® 68 Less Invasive 68 Potentially Fatal 68 Inflammatory Arthritis 68 leukemia AML 68 Plus Ribavirin 68 Postherpetic Neuralgia 68 myocardial infarction ventricular fibrillation 68 Lung Cancers 68 familial amyloidotic polyneuropathy FAP 68 Reduces Pain 68 Antifungals 68 acetonide FA 68 Pharmacokinetics PK 68 Hepatitis C Patients 68 Diabetic Macular Edema 68 Increased Mortality 68 Acute Coronary Syndromes 68 Pharmacokinetic Study 68 Telaprevir VX 68 Adenomas 68 Ischemic 68 neuropathic pain spasticity 68 Therapeutic Vaccine 68 Novel Therapeutic 68 Fludarabine 68 Treatment Naïve 68 Experimental Vaccine 68 Hepatocellular 68 Tigecycline 68 Localized Prostate Cancer 68 Hepatitis C Virus 68 Metastases 68 Thiazolidinediones 68 Adult Stem Cell Therapy 68 Antifungal 68 Kit CD# positive 68 Test Detects 68 Myelodysplastic Syndrome 68 CYP#A# CYP#D# 67 Fast Track Status 67 Sandostatin R 67 Neurodegenerative 67 RNAi Therapeutics 67 Crit Rev 67 Preclinical Evaluation 67 J Am Coll 67 lupus erythematosus 67 Immune Mediated 67 Beta Blockers 67 PresbyLens ® 67 Acute Renal Failure 67 Omacetaxine 67 RNAi Therapeutic 67 Bladder Cancer 67 Low Dose 67 Respiratory Distress 67 First Patient Treated 67 Thrombotic 67 MKC# MT 67 Iron Overload 67 Receives Fast Track 67 Pemphigus Vulgaris 67 Zorbtive TM 67 Liprotamase 67 formerly LymphoStat B 67 AVONEX ® 67 Elagolix 67 Albuferon TM 67 Rhinosinusitis 67 Oral Mucositis 67 Pafuramidine 67 Critical Limb Ischemia 67 ARIXTRA R 67 Fixed Dose 67 TO AVOID PREGNANCY WHILE 67 Osteoarthritis Patients 67 Natalizumab 67 Clot Busting 67 Arterial Disease 67 Fibromyalgia Syndrome 67 Diabetic Foot Ulcers 67 systemic juvenile idiopathic 67 Initiates Clinical Trials 67 Controlled Trial 67 Antidepressant Drug 67 Hematologic 67 Renal Cell Cancer 67 Topical Treatment 67 Neoadjuvant Chemotherapy 67 Paroxysmal Nocturnal Hemoglobinuria PNH 67 Neuroprotective Effects 67 dasatinib Sprycel 67 Panzem R 67 Mimetics 67 Renal Anemia 67 Exacerbations 67 Delayed Graft Function 67 psoriatic arthritis PsA 67 overactive bladder syndrome 67 J Clin 67 Brain Tumors 67 Schizophrenia Drug 67 Metastatic Cancer 67 Rare Genetic 67 cell lymphoma CTCL 67 Brain Atrophy 67 Novel Inhibitor 67 Gets FDA Clearance 67 Phase III Clinical Trials 67 Maven Semantic 67 Surgical Procedures 67 Cethromycin 67 Diabetic Retinopathy 67 Heartburn Drugs 67 Psoriasis Patients 67 Antibiotic Resistant 67 Kidney Failure 67 Colorectal Adenomas 67 STELARA TM 67 Boosts Survival 67 Metastatic Pancreatic Cancer 67 Urinary Tract Infections 67 Chronic lymphocytic leukemia 67 Regenerative Cells 67 Inhaled Nitric Oxide 67 Vidaza ® 67 dual endothelin receptor antagonist 67 Gene Mutation Linked 67 Randomized Double blind 67 Meta Analysis 67 Peripheral Artery Disease 67 vapreotide acetate 67 Aliskiren 67 Nonalcoholic Fatty Liver Disease 67 Pre Cancerous 67 Kepivance 67 Systemic Juvenile Idiopathic 67 Benign Prostatic Hyperplasia BPH 67 Insulin Sensitivity 67 Migraine Headaches 67 Collaborators Present 67 Endometrial 67 Ischemic Stroke 67 AVAPRO 67 HoFH 67 progressive neurodegenerative 67 Prostate Cancer Progression 67 Percutaneous Tibial Nerve Stimulation 67 Hematological Malignancies 67 Commonly Used 67 Erectile Dysfunction Drug 67 Interferon beta 1a 67 refractory chronic lymphocytic 67 Neuropathic Pain 67 deep venous thromboses 67 Clinical Efficacy 67 FASLODEX 67 diarrhea fatigue asthenia 67 gastrointestinal stromal tumors GIST 67 Ranolazine 67 topically administered 67 Immunosuppressant 67 Significantly Improves 67 Therapy Improves 67 Bronchopulmonary Dysplasia 67 Fulvestrant 67 Biogen Genentech 67 ANN INTERN MED 67 Orphan Status 67 Contrast Agents 67 Hyperparathyroidism 67 evaluating tivozanib 67 Primary Hypercholesterolemia 67 Genetic Disorder 67 Chemoradiation 67 Develop Novel 67 Insulin Glargine 67 Prostate Cancer Treatment 67 MEK Inhibitor 67 Urinary Incontinence 67 Peginterferon alfa 2b 67 Cocaine Addiction 67 Receptor Agonist 67 Bipolar Mania 67 Hedgehog Pathway Inhibitor 67 Diabetic Ulcers 67 Signaling Pathway 67 Orthostatic Hypotension 67 treat chronic sinusitis 67 Randomized Phase II 67 Bucindolol 67 Therapy Shows Promise 67 Chronic Rhinosinusitis 67 systemic fungal infections 67 AA Amyloidosis 67 Cancer Cachexia 67 polycythemia vera essential thrombocythemia 67 Antidepressants Linked 67 Diffuse Large B 67 CTAP# 67 Reduced Risk 67 Pirfenidone 67 atypical hemolytic uremic syndrome 67 Generalized Anxiety Disorder GAD 67 Initiates Dosing 67 Treatment Experienced 67 Sangamo BioSciences Announces 67 Wafer polifeprosan 67 Ribavirin causes 67 Adalimumab 67 Deforolimus 67 PEGylated anti 67 Fewer Side Effects 67 Lamotrigine 67 Mucositis 67 Unstable Angina 67 Improve Diagnosis 67 Factor Receptor 67 Effective Than 67 Thromboembolism 67 Paclitaxel Carboplatin 67 Ovarian Cancers 67 kidney urologic 67 Denufosol 67 thetreatment 67 sorafenib tablets 67 Glufosfamide 67 hypertrichosis occurred 67 Anticancer Drugs 67 subependymal giant cell 67 Glioblastoma Multiforme 67 Long Term Survival 67 Central Retinal Vein 67 Nymox NX 67 Patient Outcomes 67 Gastric Ulcers 67 beta 1a 67 Newly Diagnosed 67 Presents Preclinical Data 67 retinal vein occlusion 67 humanized interleukin 6 67 Known hypersensitivity 67 RhuDex 67 cetuximab Erbitux R 67 relapsed MM 67 Complete Remission 67 Mitral Regurgitation 67 Announces FDA Clearance 67 rasagiline tablets 67 Valopicitabine 67 Mouse Models 67 ACTEMRA TM 67 Roche Actemra 67 Statin Drugs 67 Blood Thinner 67 Mg Uk 67 headache abdominal pain 67 Helps Predict 67 Esophagitis 67 cutaneous T 67 Bosentan 67 Leber Hereditary Optic Neuropathy 67 Cardiovascular Outcomes 67 Cervical Dysplasia 67 Inhalation Aerosol 67 Predict Response 66 Prolongs Life 66 JAK2 Inhibitor 66 Chronic Lung 66 Eprodisate 66 Prognostic Value 66 Parathyroid 66 Investigational Oral 66 Antipsychotic Medications 66 Genetic Markers 66 lucinactant 66 gastrointestinal stromal tumor GIST 66 PKC# 66 Immune Cells 66 Potent Antiviral Activity 66 Immune Responses 66 Fingolimod 66 Peginterferon Alfa 2a 66 Therapeutic Vaccines 66 REMINDER ORLive Presents 66 Aurora Kinase 66 rheumatoid arthritis psoriatic arthritis 66 Demonstrates Statistically Significant 66 Stent Placement 66 BCG refractory carcinoma 66 Prodrug 66 etanercept Enbrel 66 interferon gamma 1b 66 Philadelphia Chromosome Positive 66 Cinacalcet 66 Ecallantide 66 relapsing remitting MS RRMS 66 Disease IBD 66 Intravenous Formulation 66 Spinal Fusion 66 Infusion Reactions Severe 66 Vaccine Protects Against 66 Vildagliptin 66 Orally Active 66 Colorectal Cancers 66 Fibromyalgia Pain 66 Genes Associated 66 Hepatotoxicity 66 Chronic Wounds 66 Skin Disorders 66 Chemotherapeutic Agents 66 Osteoporotic 66 Dalbavancin 66 Skin Lesions 66 either acutely decompensated 66 Reduces Risk 66 Patients Enrolled 66 Glioma 66 diarrhea predominant irritable 66 Parathyroid Hormone 66 Rheumatoid Arthritis 66 Metabolic Endocrinology 66 Cancer Treatments 66 Relapsed Refractory Aggressive 66 Hematological 66 Skin Structure Infections 66 Frozen Shoulder Syndrome 66 Physician Insights 66 Osteoporosis Treatment 66 Sirolimus Eluting Stent 66 XYOTAX TM 66 Vaccine Shows Promise 66 Improve Outcomes 66 Dasatinib 66 Circulating Tumor Cells 66 Progressive Multifocal Leukoencephalopathy 66 Tramiprosate ALZHEMED TM 66 MAGE A3 ASCI 66 generation purine nucleoside 66 Cardiovascular Disease Risk 66 Statin Therapy 66 Reperfusion Injury 66 Prognostic Significance 66 Lymphocytic 66 Acute Decompensated Heart Failure 66 Valvular Heart Disease 66 Respiratory Virus 66 Peptic Ulcer 66 Helicobacter pylori eradication 66 Infected Patients 66 secondary hyperparathyroidism 66 Bortezomib 66 Anticoagulant 66 Fibrin Patch 66 uricase 66 Inhalation Solution 66 Carcinomas 66 Heterozygous Familial Hypercholesterolemia 66 ThermoDox R 66 retinal vein occlusion induced 66 Seasonal Influenza Vaccine 66 Therapeutic Antibody 66 INTEGRILIN R 66 Bone Fractures 66 Pazopanib 66 REVLIMID R 66 VIVITROL ® 66 investigational oral inhibitor 66 Cardiotoxicity 66 Thyroid Cancer 66 Levoleucovorin 66 metastatic renal cell 66 Chemotherapy Induced 66 Vasculitis 66 Meningiomas 66 Nonspecific 66 BARACLUDE ® 66 Liver Injury 66 cytomegalovirus infection 66 Autologous Stem Cell Transplantation 66 Cholesterol Drugs 66 Blepharospasm 66 Insulin Resistance 66 Chronic Prostatitis 66 Kuvan R 66 Anti Clotting Drug 66 Hyperkalemia 66 cheilitis 66 Cognitive Deficits 66 Bivalirudin 66 Anticancer Drug 66 Poorly Controlled 66 MOVIPREP R 66 Genentech Rituxan 66 post herpetic 66 Azacitidine 66 Help Predict 66 Vaginal Gel 66 Taxane 66 Respiratory Syncytial Virus 66 Abdominal Pain 66 PENTASA 66 Shows Promise 66 Thrombocytopenia 66 dihydrochloride Tablets 66 Bronchodilator 66 alpha1 antitrypsin deficiency 66 Antiviral Therapy 66 GW# [003] 66 Fludara ® 66 Hepatitis C Genotype 66 receiving VELCADE 66 Medoxomil 66 Temsirolimus 66 Venous Thromboembolism 66 ospemifene 66 Gene Therapy Trial 66 brand ciclesonide HFA 66 Hormone Replacement 66 Genes Identified 66 Radical Prostatectomy 66 Breast Cancer Patients 66 Blood Cancers 66 metastatic gastric 66 Tasimelteon 66 active ankylosing spondylitis 66 Helps Diagnose 66 Balloon Angioplasty 66 Malignancies 66 Refractory Angina 66 Voreloxin 66 Vidaza azacitidine 66 catheter occlusion 66 metastatic colorectal 66 Adefovir 66 Epoetin Alfa 66 AVASTIN 66 Beneficial Effects 66 Stakeholder Insight 66 novel VDA molecule 66 IMiDs R 66 Cholesterol Drug 66 Confirmatory Phase 66 Mycophenolate Mofetil 66 Eur J 66 Abstract Accepted 66 First Patient Dosed 66 Febuxostat 66 juvenile idiopathic arthritis 66 Phase Ib IIa 66 Neoplasms 66 Diastolic Heart Failure 66 Breast Density 66 Gum Disease 66 gefitinib Iressa 66 LibiGel ® 66 IMiDs 66 Critically Ill Patients 66 Paroxysmal Nocturnal Hemoglobinuria 66 Blood Clots 66 Aneurysm Repair 66 Generic Version 66 Ozarelix 66 Disease Modification 66 Small Intestine 66 esophageal candidiasis 66 Pulmonary Hypertension 66 Maribavir 66 rheumatoid arthritis RA psoriatic